BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7964606)

  • 1. Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells.
    Zaides V; Yagello M; Veselovskaya T; Schmitt D; Rykova L; Fenouillet E; Gluckman JC
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2963-75. PubMed ID: 7964606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological cleavage of human immunodeficiency virus gp160 protein in infected cells as a probable factor for infection becoming chronic].
    Veselovskaia TV; Rykova LA; Selimova LM; Zaĭdes VM
    Mol Biol (Mosk); 1993; 27(1):211-21. PubMed ID: 8483471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequences in the rev-responsive element responsible for premature translational arrest in the human-immunodeficiency-virus-type-1 envelope.
    Ellerbrok H; Serpente N; Pancino G; Vanhée C; D'Auriol L; Sitbon M; Vaquero C
    Eur J Biochem; 1993 Sep; 216(2):459-67. PubMed ID: 8375384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.
    Stephens EB; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Nothnick W; Wong SW; Gunderson R; Berman NE; Singh DK
    Virology; 2002 Feb; 293(2):252-61. PubMed ID: 11886245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.
    Duensing TD; Fang H; Dorward DW; Pincus SH
    J Virol; 1995 Nov; 69(11):7122-31. PubMed ID: 7474132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines.
    Haffar OK; Nakamura GR; Berman PW
    J Virol; 1990 Jun; 64(6):3100-3. PubMed ID: 2186180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
    Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-site revertants of a simian immunodeficiency virus gp41 mutant defective in envelope glycoprotein incorporation.
    Celma CC; Manrique JM; Hunter E; Affranchino JL; González SA
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):733-41. PubMed ID: 15307919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.